Gilead Sciences saw the highest growth of 103% in patent filings in January and 140% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 103% and grants by 91%. GlobalData’s DataBook provides a comprehensive analysis of Gilead Sciences‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Gilead Sciences has been focused on protecting inventions in United States(US) with 54 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 17% filings and 19% grants. The United States(US), European Patent Office(EPO), South Korea(KR), and Japan(JP) patent Office are among the top ten patent offices where Gilead Sciences is filings its patents. Among the top granted patent authorities, Gilead Sciences has 19% of its grants in United States(US), 11% in Australia(AU) and 9% in European Patent Office(EPO).

F. Hoffmann-La Roche could be the strongest competitor for Gilead Sciences

In terms of grant share, Gilead Sciences stands in fifth position among its competitors. Gilead Sciences and F. Hoffmann-La Roche secured the top positions according to recent patent publication data.

Patents related to rare diseases and cell & gene therapy lead Gilead Sciences's portfolio

Gilead Sciences has the highest number of patents in rare diseases followed by, cell & gene therapy and climate change. For rare diseases, nearly 29% of patents were filed and 41% of patents were granted in Q1 2024.

Human immunodeficiency virus (hiv) infections (aids) related patents lead Gilead Sciences portfolio followed by viral infections, and cell therapy

Gilead Sciences has highest number of patents in human immunodeficiency virus (hiv) infections (aids) followed by viral infections, cell therapy, hepatitis b, and non-alcoholic steatohepatitis (nash). For human immunodeficiency virus (hiv) infections (aids), nearly 8% of patents were filed and 9% of patents were granted in Q1 2024.

For comprehensive analysis of Gilead Sciences's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.